LILY34:BVMF
Eli Lilly And Company BDR
196,79 BRL
0,00%
(0,00) 1D
9-окт., 17:06:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
195,67 BRL
High
196,79 BRL
Low
191,80 BRL
Mkt. cap
1,11 трлн
Avg. vol.
36,60 миң
Volume
41,76 миң
52-wk high
223,07 BRL
52-wk low
141,56 BRL
Shares outstanding
941,36 млн
No. of employees
50 миң
Open
195,67 BRL
High
196,79 BRL
Low
191,80 BRL
Mkt. cap
1,11 трлн
Avg. vol.
36,60 миң
Volume
41,76 миң
52-wk high
223,07 BRL
52-wk low
141,56 BRL
Shares outstanding
941,36 млн
No. of employees
50 миң
News stories
From web sources and news partners
24/7 Wall St.
·
19 саат мурун
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Investing.com
·
21 саат мурун
Lilly presents exploratory biomarker data from psoriasis study
Stock Traders Daily
·
23 саат мурун
Discipline and Rules-Based Execution in LLY Response
Fierce Biotech
·
23 саат мурун
TRex rakes in $117M IPO, while Retension reveals $45M listing
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50 миң
Founded1876
HeadquartersИндианаполис, Индиана, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitelilly.com